American Well Corporation
NYSE:AMWLMedical - Healthcare Information Services
+$0.24 today
- Market cap
- $171.77M
- Beta
- 1.70
- P/E (TTM)
- -1.6
- EPS (TTM)
- -$5.30
Volume 0.06M
Average 0.07M
AMWL Debt Repayment
Cash used to repay borrowings during the period.
American Well CorporationNYSE: AMWL
Debt Repayment · Q1 FY2026 · quarter ended Mar 2026
Debt repayment outflow grows to $0
Q1 FY2026 debt repayment was $0, compared with $0 a year earlier. Trailing-twelve-month debt repayment was $0.
Context
- Debt repayment amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Debt repayment increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly debt repayment holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Debt Repayment history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Debt Repayment | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Debt Repayment vs competitors
How AMWL compares with its peers on the latest reported figures
- AMWL's LTM Mar 2026 debt repayment of $0 is the 6th largest of the 9 companies compared; the peer median is $0.
- Debt repayment amounts to 0.0% of revenue for AMWL, versus a peer median of 9.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $2.67M | +178.3% | — | — | |
| LTM Jun 2026 | $2.22M | — | +16.6% | 18.2% | |
| LTM Mar 2026 | $550K | +8.5% | +101.4% | 289.5% | |
| LTM Mar 2026 | $471K | +60.2% | — | — | |
| LTM Mar 2026 | $40K | +105.2% | — | 1.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | +100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding AMWL) | $0 | +100.0% | +59.0% | 9.6% | |
Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (176.78M) | (272.07M) | (675.16M) | (208.14M) | (95.7M) |
| Depreciation & Amortization | 16.09M | 26.17M | 31.92M | 33.43M | 33.96M |
| Deferred Income Tax | (6.25M) | (2.52M) | (242K) | (243K) | (1.11M) |
| Stock-Based Compensation | 43.81M | 67.68M | 72.25M | 47.54M | 22.01M |
| Change in Working Capital | (27.72M) | (28.1M) | (15.51M) | (9.98M) | (26.8M) |
| Accounts Receivables | (512K) | (8.14M) | 3.25M | (25.01M) | 12.22M |
| Inventory | 1.6M | (1.21M) | 2.09M | 1.9M | 1.17M |
| Accounts Payables | 5.55M | (4.78M) | (2.36M) | 159K | (3.42M) |
| Other Working Capital | (34.35M) | (13.97M) | (18.48M) | 12.97M | (36.77M) |
| Other Non-Cash Items | 9.31M | 16.53M | 438.4M | 57.6M | 1.68M |
| Operating Cash Flow | (141.54M) | (192.32M) | (148.34M) | (127.34M) | (65.95M) |
| Capital Expenditures | (559K) | (10.45M) | (15.25M) | (15.22M) | (21K) |
| Acquisitions (Net) | (159.07M) | (1.96M) | 0 | (3.43M) | 18.32M |
| Purchases of Investments | 2.55M | (499.22M) | (389.99M) | 0 | (1M) |
| Sales of Investments | 100M | 500M | 389.99M | 0 | 0 |
| Other Investing Activities | (2.55M) | 0 | (18.88M) | (15.1M) | (196K) |
| Investing Cash Flow | (59.63M) | (11.63M) | (19.17M) | (18.65M) | 17.1M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 844K |
| Common Stock Repurchased | (15.04M) | (360K) | (586K) | (3K) | (4K) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 20.79M | (3.25M) | 2.73M | 1.38M | 0 |
| Financing Cash Flow | 5.75M | (3.61M) | 2.15M | 1.38M | 840K |
| Effect of Forex Changes | (84K) | (305K) | (1.14M) | 887K | 2.02M |
| Net Change in Cash | (195.5M) | (207.87M) | (166.51M) | (143.72M) | (45.99M) |
| Free Cash Flow | (142.1M) | (202.77M) | (163.59M) | (142.56M) | (65.97M) |
American Well Corporation
NYSE:AMWL
Intrinsic Alpha fair value
Locked
Current Price
$11.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.